Colibacter massiliensis gen. nov. sp. nov., a novel Gram-stain-positive anaerobic diplococcal bacterium, isolated from the human left colon.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 11 2019
Historique:
received: 06 02 2019
accepted: 06 11 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 13 11 2020
Statut: epublish

Résumé

The gut microbiota is considered to play a key role in human health. As a consequence, deciphering its microbial diversity is mandatory. A polyphasic taxonogenomic strategy based on the combination of phenotypic and genomic analyses was used to characterize a new bacterium, strain Marseille-P2911. This strain was isolated from a left colon sample of a 60-year old man who underwent a colonoscopy for an etiological investigation of iron-deficiency anemia in Marseille, France. On the basis of 16S rRNA sequence comparison, the closest phylogenetic neighbor was Anaeroglobus geminatus (94.59% 16S rRNA gene sequence similarity) within the family Veillonellaceae. Cells were anaerobic, Gram-stain-positive, non-spore-forming, catalase/oxidase negative cocci grouped in pairs. The bacterium was able to grow at 37 °C after 2 days of incubation. Strain Marseille-P2911 exhibited a genome size of 1,715,864-bp with a 50.2% G + C content, and digital DNA-DNA hybridization (dDDH) and OrthoANI values with A. geminatus of only 19.1 ± 4.5% and 74.42%, respectively. The latter value being lower than the threshold for genus delineation (80.5%), we propose the creation of the new genus Colibacter gen. nov., with strain Marseille-P2911

Identifiants

pubmed: 31748674
doi: 10.1038/s41598-019-53791-1
pii: 10.1038/s41598-019-53791-1
pmc: PMC6868274
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17199

Références

Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Int J Syst Evol Microbiol. 2014 Feb;64(Pt 2):384-391
pubmed: 24505076
Adv Immunol. 2010;107:243-74
pubmed: 21034976
Int J Syst Evol Microbiol. 2017 Jul;67(7):2114-2120
pubmed: 28742009
Int J Syst Evol Microbiol. 2006 Apr;56(Pt 4):695-702
pubmed: 16585679
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):6438-6443
pubmed: 28588144
Int J Syst Evol Microbiol. 2005 Nov;55(Pt 6):2471-2478
pubmed: 16280512
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
Nat Microbiol. 2016 Nov 07;1:16203
pubmed: 27819657
Bioinformatics. 2011 Feb 1;27(3):431-2
pubmed: 21149340
Sci Rep. 2019 May 28;9(1):7931
pubmed: 31138831
Int J Syst Evol Microbiol. 2016 Feb;66(2):1100-1103
pubmed: 26585518
Antimicrob Agents Chemother. 2014;58(1):212-20
pubmed: 24145532
J Clin Microbiol. 2013 Jul;51(7):2182-94
pubmed: 23637301
Bioinformatics. 2011 Feb 15;27(4):578-9
pubmed: 21149342
Anaerobe. 2015 Dec;36:73-8
pubmed: 26514403
New Microbes New Infect. 2015 Jun 09;7:48-9
pubmed: 26199732
Clin Microbiol Infect. 2012 Dec;18(12):1185-93
pubmed: 23033984
Trends Microbiol. 1996 Nov;4(11):430-5
pubmed: 8950812
Clin Microbiol Infect. 2013 Feb;19(2):141-60
pubmed: 22117544
Microbiol Resour Announc. 2019 Aug 1;8(31):
pubmed: 31371545
Int J Syst Evol Microbiol. 2002 May;52(Pt 3):983-986
pubmed: 12054267
Curr Opin Gastroenterol. 2013 Jan;29(1):49-54
pubmed: 23041677
Genome Biol. 2012 Jun 25;13(6):R56
pubmed: 22731987
Appl Microbiol. 1959 Jan;7(1):16-22
pubmed: 13617940
BMC Bioinformatics. 2013 Feb 21;14:60
pubmed: 23432962
Stand Genomic Sci. 2016 Apr 14;11:32
pubmed: 27087892
Clin Microbiol Rev. 2015 Jan;28(1):237-64
pubmed: 25567229
Stand Genomic Sci. 2010 Jan 28;2(1):117-34
pubmed: 21304684
PLoS One. 2013 Oct 28;8(10):e77302
pubmed: 24204795
Nucleic Acids Res. 2015 Jul 1;43(W1):W237-43
pubmed: 25948579
PLoS One. 2013 Nov 18;8(11):e79353
pubmed: 24260205
Cell. 2006 Feb 24;124(4):837-48
pubmed: 16497592
New Microbes New Infect. 2016 Jan 11;10:66-76
pubmed: 26937282
Stand Genomic Sci. 2013 Aug 07;8(3):525-38
pubmed: 24501636
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
New Microbes New Infect. 2016 Nov 24;17:23-24
pubmed: 28275434
J Clin Microbiol. 2000 Oct;38(10):3623-30
pubmed: 11015374
Antonie Van Leeuwenhoek. 2017 Oct;110(10):1327-1337
pubmed: 28389704
Int J Syst Evol Microbiol. 2003 Mar;53(Pt 2):547-553
pubmed: 12710625

Auteurs

Hussein Anani (H)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Service de Santé des Armées, AP-HM, UMR Vecteurs Infections Tropicales et Méditeranéennes (VITROME), Marseille, France.
Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.

Rita Abou Abdallah (RA)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Service de Santé des Armées, AP-HM, UMR Vecteurs Infections Tropicales et Méditeranéennes (VITROME), Marseille, France.
Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.

May Khoder (M)

Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.

Anthony Fontanini (A)

Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.

Morgane Mailhe (M)

Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.

Davide Ricaboni (D)

Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.

Didier Raoult (D)

Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.
Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.

Pierre-Edouard Fournier (PE)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Service de Santé des Armées, AP-HM, UMR Vecteurs Infections Tropicales et Méditeranéennes (VITROME), Marseille, France. pierre-edouard.fournier@univ-amu.fr.
Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France. pierre-edouard.fournier@univ-amu.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH